These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19879118)

  • 21. Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand.
    Kongchayanun C; Vilaichone RK; Pornthisarn B; Amornsawadwattana S; Mahachai V
    Helicobacter; 2012 Aug; 17(4):282-5. PubMed ID: 22759328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.
    Choli-Papadopoulou T; Kottakis F; Papadopoulos G; Pendas S
    World J Gastroenterol; 2011 Jun; 17(21):2585-91. PubMed ID: 21677824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
    Kudo T; Fujinami H; Ando T; Nishikawa J; Ogawa K; Hosokawa A; Orihara T; Murakami J; Takahara T; Sugiyama T
    Helicobacter; 2012 Aug; 17(4):277-81. PubMed ID: 22759327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
    Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
    Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
    Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
    Vcev A; Vceva A; Kurbel S; Takac B; Stimac D; Ivandić A; Ostojić R; Barbir A; Hovat D; Mihaljević S
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):939-41. PubMed ID: 11802510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
    Cetinkaya ZA; Sezikli M; Güzelbulut F; Coşgun S; Düzgün S; Kurdaş OO
    Helicobacter; 2010 Apr; 15(2):143-7. PubMed ID: 20402816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers.
    Ghazzawi IM; Obeidat WA; Zuriekat FA
    Saudi Med J; 2004 Aug; 25(8):1006-9. PubMed ID: 15322588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
    Sito E; Konturek PC; Bielański W; Kwiecień N; Konturek SJ; Baniukiewicz A; Jedynak M; Gabryelewicz A; Hahn EG
    J Physiol Pharmacol; 1996 Mar; 47(1):221-8. PubMed ID: 8777303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G; Parente F; Russo A; Vago L; Imbesi V; Bianchi Porro G
    Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.
    Cosme A; Montes M; Martos M; Gil I; Mendarte U; Salicio Y; Piñeiro L; Recasens MT; Ibarra B; Sarasqueta C; Bujanda L
    Clin Microbiol Infect; 2013 Apr; 19(4):379-83. PubMed ID: 22512623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
    Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
    Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.